ProfileGDS4890 / 241496_at
TitleSystemic lupus erythematosus patients and yellow fever vaccine-immunized healthy donors: CD16+ monocytes
OrganismHomo sapiens


SLE 1 SLE 2 SLE 3 SLE 4 ND 55 ND 56 ND 57 systemic lupus erythematosus healthy not immunized before YFV immunization after YFV immunization before YFV immunization after YFV immunization before YFV immunization after YFV immunization GSM1256968 GSM1256969 GSM1256970 GSM1256971 GSM1256988 GSM1256991 GSM1256989 GSM1256992 GSM1256990 GSM1256993 52% 13% 39% 39% 34% 37% 33% 47% 41% 57% sort by individual sort by disease state sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1256968SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 115.81252
GSM1256969SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 21.3172313
GSM1256970SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 39.1203539
GSM1256971SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 49.6725439
GSM1256988Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 55 before YFV6.9393534
GSM1256991Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 55 seven days after YFV8.5667237
GSM1256989Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 56 before YFV8.1159133
GSM1256992Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 56 seven days after YFV13.635947
GSM1256990Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 57 before YFV11.168641
GSM1256993Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 57 seven days after YFV21.290457